A Johnson County nonprofit could face grant funding cuts under President Donald Trump’s proposed 2026 federal budget.

AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

The rumors about Elon Musk’s rampant White House ketamine use have circled back to a source: Donald Trump.

Right handers Seth Johnson, Alan Rangel latest IronPigs to deal with yo-yo roles between starting and relief pitchers. Both ...

U.S health officials are updating the prescribing labels of long-acting ADHD medications to carry new warnings for children ...

Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved IMAAVY™ (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, for the ...

U.S. FDA Orphan drug status for wAIHA in December 2019, HDFN in June 2020, gMG in February 2021, chronic inflammatory demyelinating polyneuropathy (CIDP) in October 2021 and FNAIT in December 2023 ...

How Johnson & Johnson has somehow survived scandal after scandal By Eric Spitznagel Published April 12, 2025, 2:00 p.m. ET ...

Johnson & Johnson has announced plans to acquire Ambrx, a clinical-stage biopharmaceutical company specializing in antibody drug conjugates (ADCs), for ~$2.0 billion. ADCs have become a popular ...

T he Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed ...

Johnson and Johnson MedTech got FDA approval for a safer heart treatment workflow that reduces the risk of cancer for patients and providers. The approval is the first and only of its kind.

Johnson & Johnson is allowing Stop TB Partnership, a Switzerland-based nonprofit, to distribute a generic version of its tuberculosis drug SIRTURO, or bedaquiline, in low- and middle-income ...